UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ------------ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2006 QMED, INC. (Exact Name of Registrant as Specified in Charter) Delaware 0-11411 22-2468665 (State or Other Jurisdiction (Commission File Number) (I.R.S. Employer of Incorporation) Identification Number) 25 Christopher Way Eatontown, New Jersey 07724 (Address of Principal Executive Offices) (Zip Code) (732) 544-5544 (Registrant's Telephone Number, Including Area Code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c)) Item 1.01. Entry into a Material Definitive Agreement. On August 24, 2006, the Registrant and Michael Cox, its President and Chief Executive Officer, entered into an amendment (the "Amendment") effective as of August 23, 2006, of Mr. Cox's employment agreement dated as of December 1, 2002. The Amendment amends certain severance provisions and provides, among other things, that the Registrant will pay Mr. Cox three times his base salary in severance payable in three annual installments and continue his health benefits for three years after termination if his employment is terminated under certain circumstances. In addition, upon expiration of the employment agreement or Mr. Cox's resignation (other than for Good Reason, as defined), Mr. Cox will be given an opportunity to consult for the Registrant for two years at a rate of 75% of his last base salary. The above description is qualified in its entirety by the Amendment, attached hereto as Exhibit 10.1 Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Amendment to Employment Agreement effective as of August 23, 2006 between the Registrant and Michael Cox. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. QMED, INC. By: /s/ William T. Schmitt, Jr. William T. Schmitt, Jr. Senior Vice President, Treasurer & Chief Financial Officer Date: August 29, 2006 3 EXHIBIT INDEX Exhibit Number Description 10.1 Amendment to Employment Agreement effective as of August 23, 2006 between the Registrant and Michael Cox. 4

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

____________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 19, 2007

___________________________________________________________

QMED, INC.

(Exact Name of Registrant as Specified in Charter)

___________________________________________________________

Delaware

0-11411

22-2468665

(State or Other Jurisdiction

(Commission File Number)

(I.R.S. Employer

of Incorporation)

Identification Number)

25 Christopher Way

Eatontown, New Jersey 07724

(Address of Principal Executive Offices) (Zip Code)

(732) 544-5544

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02.

Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On March 19, 2007, Michael W. Cox and David Feldman informed QMed, Inc. (the “Company”) that they will not stand for reelection to the Company’s Board of Directors.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

QMED, INC.

By: /s/ William T. Schmitt, Jr.

William T. Schmitt, Jr.

Senior Vice President, Treasurer

& Chief Financial Officer

Date:

March 21, 2007

Filing Compare · QMED INC